The guidance reflects a sequential improvement from first to second-half growth primarily driven by the gradual recovery of supply throughout the year, 2022 normalization from private label business, the recovery of
The approval by the European Commission follows the positive opinion of the Committee for Medicinal Products for Human Use and is based on results from the ELEVATE-PLUS trials published in the American Society of
Operating income is expected to remain flat or decline by up to a high-single-digit percentage rate in 2023.
By 2025 Fresenius Medical Care targets to achieve an improved operating income margin of 10 to 14%.
1Life Healthcare Inc (NASDAQ: ONEM) shares are surging in after-hours trading Tuesday following reports the Federal Trade Commission won't challenge Amazon.com Inc's (NASDAQ: AMZN)
The U.S. Supreme Court refused to hear Johnson & Johnson's (NYSE: JNJ) regarding a $302 million judgment in a lawsuit brought by California, accusing the company of concealing the risks of its pelvic mesh products.
Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced additional interim data from a Phase 2 open-label extension (OLE) study of donidalorsen for hereditary angioedema. …